BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6403951)

  • 1. Open-field behavior in dopamine-depleted rat pups and their mothers.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
    Concannon JT; Braughler JM; Schechter MD
    Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.
    Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG
    Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).
    Lipton SV; McGough JP; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 6-hydroxydopamine-induced catecholamine depletion on shock-precipitated wall climbing of infant rat pups.
    Emerich DF; Scalzo FM; Enters EK; Spear NE; Spear LP
    Dev Psychobiol; 1985 May; 18(3):215-27. PubMed ID: 3921418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup.
    Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):391-6. PubMed ID: 882577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of water-deprivation on locomotor activity in rats treated with 6-hydroxydopamine.
    Seiden LS; Pachman SH; Heffner TG; Shaughnessy RA; Vosmer G
    Brain Res; 1985 Jul; 337(2):225-32. PubMed ID: 3928086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal pup brain dopamine depletion inhibits maternal behavior.
    Wilkins AS; Logan M; Kehoe P
    Pharmacol Biochem Behav; 1997 Dec; 58(4):867-73. PubMed ID: 9408188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine.
    Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ
    Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of maternal and sibling presence of hyperactivity of 6-hydroxydopamine-treated developing rats.
    Teicher MH; Shaywitz BA; Kootz HL; Cohen DJ
    J Comp Physiol Psychol; 1981 Feb; 95(1):134-45. PubMed ID: 7217408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of apomorphine in 6-hydroxydopamine-treated and aged rats.
    Schechter MD; Concannon JT
    Psychopharmacology (Berl); 1984; 83(1):99-103. PubMed ID: 6429708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
    Heffner TG; Seiden LS
    Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-OHDA induced effects upon the acquisition and performance of specific locomotor tasks in rats.
    Watson M; McElligott JG
    Pharmacol Biochem Behav; 1983 Jun; 18(6):927-34. PubMed ID: 6412249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing rat.
    Raskin LA; Shaywitz BA; Anderson GM; Cohen DJ; Teicher MH; Linakis J
    Pharmacol Biochem Behav; 1983 Nov; 19(5):743-9. PubMed ID: 6647508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.